Literature DB >> 9295846

Therapeutic electrical stimulation following selective posterior rhizotomy in children with spastic diplegic cerebral palsy: a randomized clinical trial.

P Steinbok1, A Reiner, J R Kestle.   

Abstract

A randomized controlled trial was carried out to determine the effectiveness of therapeutic electrical stimulation (TES) in improving the function of children with spastic cerebral palsy (CP), who had undergone selective posterior lumbosacral rhizotomy more than a year previously. Children were randomly assigned to groups to receive TES for 1 year, or to have no TES. The primary outcome was the change in the Gross Motor Function Measure (GMFM), a quantitative and validated measure for use in children with spastic CP. There was a statistically significant and clinically important improvement in outcome for the treated children, with the mean change in the GMFM score at one year being 5.5% compared with 1.9% in the untreated group (P = 0.001). TES was simple to use, had no significant complications, and was well accepted by the children and their caregivers, as indicated by an average compliance of 93% for the application of TES on a nightly basis over the course of the study. It was concluded that TES may be beneficial in children with spastic CP who have undergone a selective posterior rhizotomy procedure more than 1 year previously.

Entities:  

Mesh:

Year:  1997        PMID: 9295846     DOI: 10.1111/j.1469-8749.1997.tb07479.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  3 in total

1.  Does threshold nighttime electrical stimulation benefit children with spina bifida? A pilot study.

Authors:  Janet L Walker; Shelley W Ryan; Tonya R Coburn
Journal:  Clin Orthop Relat Res       Date:  2011-05       Impact factor: 4.176

Review 2.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

3.  Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.

Authors:  T Ubhi; B B Bhakta; H L Ives; V Allgar; S H Roussounis
Journal:  Arch Dis Child       Date:  2000-12       Impact factor: 3.791

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.